Sign in

    Chun-Wai Yong

    Managing Director and Equity Analyst at UBS

    Chun-Wai Yong is a Managing Director and Equity Analyst at UBS, specializing in the coverage of the Greater China financials sector, with a primary focus on major Chinese and Hong Kong banks such as Bank of China, ICBC, China Construction Bank, and Bank of East Asia. He is recognized for his rigorous research and investment recommendations, earning strong performance metrics with a five-star analyst ranking on platforms like TipRanks, a success rate consistently above 60%, and average annualized returns that outpace the sector benchmark. Yong began his career in the early 2000s and has held equity research positions at major global banks, including Crédit Suisse and Lehman Brothers, before joining UBS in 2010. He holds FINRA Series 7, 63, and 86/87 licenses, and is frequently cited in financial press for his insights on the Chinese banking industry.

    Chun-Wai Yong's questions to eHealth (EHTH) leadership

    Chun-Wai Yong's questions to eHealth (EHTH) leadership • Q1 2025

    Question

    Chun-Wai Yong asked about the Department of Justice litigation's impact on carrier marketing discussions and whether eHealth is developing other ancillary services to drive retention and diversify revenue streams.

    Answer

    CEO Fran Soistman stated it was too soon to see an impact from the DOJ complaint on carrier discussions, noting that the issue of sponsorship programs is limited to a handful of carriers. He characterized eHealth's current ancillary services as being in their 'infancy' and not yet a meaningful revenue contributor, though they are theoretically believed to aid retention over the long term.

    Ask Fintool Equity Research AI